Showing results (121-130 of 289) with videos related to

Sort By:
Pageof 29
Cancer Immunology Research|November 1, 2024
Alternate MHC I Antigen Presentation Pathways Allow CD8+ T-cell Recognition and Killing of Cancer Cells in the Absence of β2M or TAPFreidrich M Cruz, Laura A A Orellano, Amanda Chan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2022
Tetraspanin-5-mediated MHC class I clustering is required for optimal CD8 T cell activationJeff D Colbert, Freidrich M Cruz, Christina E Baer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2009
Direct antigen presentation and gap junction mediated cross-presentation during apoptosisBaoxu Pang, Joost Neijssen, Xiaohang Qiao, et al.
Journal of Cell Science|September 10, 2020
Invariant chain regulates endosomal fusion and maturation through an interaction with the SNARE Vti1bAzzurra Margiotta, Dominik M Frei, Ingrid Hegnes Sendstad, et al.
STAR Protocols|December 17, 2021
Spatially resolved sampling of the human oral cavity for metabolic profilingAlessio Ciurli, Rico J E Derks, Maximilian Liebl, et al.
Trends in Immunology|May 9, 2020
Opportunities for Small Molecules in Cancer ImmunotherapySabina Y van der Zanden, Jolien J Luimstra, Jacques Neefjes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentationIan A York, Nidhi Bhutani, Sophia Zendzian, et al.
Trends in Immunology|February 26, 2014
Re-examining class-I presentation and the DRiP hypothesisKenneth L Rock, Diego J Farfán-Arribas, Jeff D Colbert, et al.
Pageof 29